Nrf2 is associated with the regulation of basal transcription activity of the BRCA1 gene

Acta Biochimica et Biophysica Sinica

Volumn 45, Issue 3, 2013, Pages 179-187

  Wang, Qiaoqiao ^a   Li, Jiyu ^a   Yang, Xinmiao ^b   Sun, Hefen ^a   Gao, Shuiping ^a   Zhu, Hua ^c   Wu, Jiong ^a   Jin, Wei ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^c RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

BRCA1; breast cancer; histone acetylation; Nrf2; promoter

Indexed keywords

ANTIOXIDANT; BONE SIALOPROTEIN (35 62), HUMAN; BONE SIALOPROTEIN (35-62), HUMAN; BRCA1 PROTEIN; E1A ASSOCIATED P300 PROTEIN; EP300 PROTEIN, HUMAN; HISTONE; NFE2L2 PROTEIN, HUMAN; PEPTIDE FRAGMENT; SIALOGLYCOPROTEIN; TRANSCRIPTION FACTOR NRF2;

ARTICLE; BREAST TUMOR; DNA RESPONSIVE ELEMENT; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; HUMAN; METABOLISM; MUTAGENESIS; PROMOTER REGION; TRANSCRIPTION INITIATION; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

ANTIOXIDANTS; BRCA1 PROTEIN; BREAST NEOPLASMS; CELL LINE, TUMOR; E1A-ASSOCIATED P300 PROTEIN; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; HISTONES; HUMANS; MUTAGENESIS; NF-E2-RELATED FACTOR 2; PEPTIDE FRAGMENTS; PROMOTER REGIONS, GENETIC; RESPONSE ELEMENTS; SIALOGLYCOPROTEINS; TRANSCRIPTIONAL ACTIVATION;

EID: 84874389650     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmt001     Document Type: Article

References (31)

1. Miki Y, Swensen J, Shattuckeidens D, Futreal PA, Harshman K, Tavtigian S and Liu QY, et al. A strong candidate for the breast and ovarian-cancer susceptibility gene BRCA1. Science 1994, 266: 66-71.
2. Wilson CA, Ramos L, Villasenor MR, Anders KH, Press MF, Clarke K and Karlan B, et al. Localization of human BRCA1 and its loss in highgrade, non-inherited breast carcinomas. Nat Genet 1999, 21: 236-240.
3. Mueller CR and Roskelley CD. Regulation of BRCA1 expression and its relationship to sporadic breast cancer. Breast Cancer Res 2003, 5: 45-52.
4. Turner N, Tutt A and Ashworth A. Hallmarks of 'BRCAness' in sporadic cancers. Nat Rev Cancer 2004, 4: 814-819.
5. Wang A, Schneider-Broussard R, Kumar AP, MacLeod MC and Johnson DG. Regulation of BRCA1 expression by the Rb-E2F pathway. J Biol Chem 2000, 275: 4532-4536.
6. Oberley MJ, Inman DR and Farnham PJ. E2F6 negatively regulates BRCA1 in human cancer cells without methylation of histone H3 on lysine 9. J Biol Chem 2003, 278: 42466-42476.
7. MacLachlan TK, Dash BC, Dicker DT and EI-Deiry WS. Repression of BRCA1 through a feedback loop involving p53. J Biol Chem 2000, 275: 31869-31875.
8. Beger C, Pierce LN, Kruger M, Marcusson EG, Robbins JM, Welcsh P and Welch PJ, et al. Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach. Proc Natl Acad Sci USA 2001, 98: 130-135.
9. Baldassarre G, Battista S, Belletti B, Thakur S, Pentimalli F, Trapasso F and Fedele M, et al. Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma. Mol Cell Biol 2003, 23: 2225-2238.
10. Rauch T, Zhong XY, Pfeifer GP and Xu XZ. 53BP1 is a positive regulator of the BRCA1 promoter. Cell Cycle 2005, 4: E55-E60.
11. Jeffy BD, Hockings JK, Kemp MQ, Morgan SS, Hager JA, Beliakoff J and Whitesell LJ, et al. An estrogen receptor-alpha/p300 complex activates the BRCA-1 promoter at an AP-1 site that binds Jun/Fos transcription factors: repressive effects of p53 on BRCA-1 transcription. Neoplasia 2005, 7: 873-882.
12. Hockings JK, Degner SC, Morgan SS, Kemp MQ and Romagnolo DF. Involvement of a specificity proteins-binding element in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene. Breast Cancer Res 2008, 10: R29.
13. Jin W, Chen L, Chen Y, Xu SG, Di GH, Yin WJ and Wu J, et al. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer. Breast Cancer Res Treat 2010, 123: 359-373.
14. Jin W, Liu Y, Chen L, Zhu H, Di GH, Ling H and Wu J, et al. Involvement of MyoD and c-myb in regulation of basal and estrogeninduced transcription activity of the BRCA1 gene. Breast Cancer Res Treat 2011, 125: 699-713.
15. Corkery D, Thillainadesan G, Coughlan N, Mohan RD, Isovic M, Tini M and Torchia J. Regulation of the BRCA1 gene by an SRC3/53BP1 complex. BMC Biochem 2011, 12: 50.
16. Rosen EM, Fan S, Pestell RG and Goldberg ID. BRCA1 gene in breast cancer. J Cell Physiol 2003, 196: 19-41.
17. Schlegel BP, Green VJ, Ladias JA and Parvin JD. BRCA1 interaction with RNA polymerase II reveals a role for hRPB2 and hRPB10alpha in activated transcription. Proc Natl Acad Sci USA 2000, 97: 3148-3153.
18. Anderson SE, Schlegel BP, Nakajima T, Wolpin ES and Parvin JD. BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase a. Nat Genet 1998, 19: 254-256.
19. Pao GM, Janknecht R, Ruffner H, Hunter T and Verma IM. CBP/p300 interact with and function as transcriptional coactivators of BRCA1. Proc Natl Acad Sci USA 2000, 97: 1020-1025.
20. Yarden RI and Brody LC. BRCA1 interacts with components of the histone deacetylase complex. Proc Natl Acad Sci USA 1999, 96: 4983-4988.
21. Yu X, Wu LC, Bowcock AM, Aronheim A and Baer R. The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression. J Biol Chem 1998, 273: 25388-25392.
22. Bae I, Fan S, Meng Q, Rih JK, Kim HJ, Kang HJ and Xu J, et al. BRCA1 induces antioxidant gene expression and resistance to oxidative stress. Cancer Res 2004, 64: 7893-7909.
23. Kang HJ, Hong YB, Kim HJ, Rodriguez OC, Nath RG, Tilli EM and Albanese C, et al. Detoxification: a novel function of BRCA1 in tumor suppression? Toxicol Sci 2011, 122: 26-37.
24. Dinkova-Kostova AT, Holtzclaw WD, Cole RN, Itoh K, Wakabayashi N, Katoh Y and Yamamoto M, et al. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci USA 2002, 99: 11908-11913.
25. Kobayashi M and Yamamoto M. Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Adv Enzyme Regul 2006, 46: 113-140.
26. Kensler TW and Wakabayashi N. Nrf2: friend or foe for chemoprevention? Carcinogenesis 2010, 31: 90-99.
27. Slocum SL and Kensler TW. Nrf2: control of sensitivity to carcinogens. Arch Toxicol 2011, 85: 273-284.
28. Xu J, Huo D, Chen Y, Nwachukwu C, Collins C, Rowell J and Slamon DJ, et al. CpG island methylation affects accessibility of the proximal BRCA1 promoter to transcription factors. Breast Cancer Res Treat 2010, 120: 593-601.
29. Ogryzko VV, Schiltz RL, Russanova V, Howard BH and Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 1996, 87: 953-959.
30. Liu L, Scolnick DM, Trievel RC, Zhang HB, Marmorstein R, Halazonetis TD and Berger SL. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol Cell Biol 1999, 19: 1202-1209.
31. Vo N and Goodman RH. CREB-binding protein and p300 in transcriptional regulation. J Biol Chem 2001, 276: 13505-13508.